Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin
AssigneeElwha LLC
InventorsRoderick A. Hyde, Wayne R. Kindsvogel, Gary L. McKnight
Life of this patent
Estimating the term…
Abstract
Compositions and methods are disclosed herein for producing one or more immunoglobulins in an isolated cytotoxic B lymphocyte cell line. An isolated cell line includes an isolated B lymphocyte cell line capable of expressing at least one exogenously incorporated membrane immunoglobulin reactive to a first antigen and at least one endogenous secreted immunoglobulin reactive to a second antigen, and further capable of expressing at least one exogenously incorporated recombinant B cell receptor that signals for expression of cytotoxic effector molecules.
Claims18
An isolated modified B cell comprising:
- at least one exogenously incorporated membrane immunoglobulin or a recombinant B cell receptor that is reactive to a first antigen and at least one endogenous secreted immunoglobulin reactive to a second antigen;
- wherein the isolated B cell is capable of expressing cytotoxicity for at least one target cell.
An isolated recombinant B cell comprising:
- at least one exogenously incorporated membrane immunoglobulin or recombinant B cell receptor that is reactive to a first antigen and at least one exogenously incorporated nucleic acid encoding secreted immunoglobulin reactive to a second antigen;
- wherein the isolated B cell is capable of expressing cytotoxicity for at least one target cell.
Dependencies are inferred from the claim text.